Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jun;7(2):87-94.
doi: 10.1007/s11325-003-0087-7.

Nasal breathing and continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA)

Affiliations

Nasal breathing and continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA)

Jan H Hollandt et al. Sleep Breath. 2003 Jun.

Abstract

Although nasal continuous positive airway pressure (nCPAP) treatment is the most efficient therapy for obstructive sleep apnea (OSA), compliance with therapy is poor because of several side effects. Among these adverse effects some are related to the reactions of the nose to nCPAP which are briefly described. In a long-term survey of 109 OSA patients, 80.6% continued nCPAP for at least 3 years until the last follow-up. Follow-up ranged between 0.8 and 109 months with a mean time of 43 (SD +/- 24.7) months. Among all patients treated with nCPAP, only 46.6% met our criteria for long-term compliance, defined as a mean use of the CPAP machine for at least 5 hours per night. Within the objective measures such as age, body mass index, neck circumference, nasal airflow, apnea-hypopnea index, minimal oxygen saturation, and level of nCPAP pressure, no predictive factor for daily use of nCPAP could be found. However, pretherapeutic daytime somnolence (measured by visual analogue scale and Epworth Sleepiness Scale) and its improvement obtained from the therapy showed a significant effect on the daily use of the CPAP machine.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Med Klin (Munich). 1994 Feb 15;89(2):86-8, 107 - PubMed
    1. J Clin Invest. 1985 Oct;76(4):1375-81 - PubMed
    1. Chest. 1995 Feb;107(2):375-81 - PubMed
    1. Thorax. 1995 Oct;50(10):1106-13 - PubMed
    1. Lancet. 1981 Apr 18;1(8225):862-5 - PubMed

LinkOut - more resources